Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10386189 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL5362188 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL2798260 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL5362193 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL16059073 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL2799138 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL16059072 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL15791893 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL10386188 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 | |
| SCHEMBL28895769 | 1.00 | LCK (0.48) | LCKPPARDZDHHC20ZDHHC2ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125849-B1 | SULFOGLYCOLIPID ANTIGENS, THEIR PROCESS OF PREPARATION, AND THEIR USE AGAINST TUBERCULOSIS | CENTRE NAT DE LA RECH SCIENT (C N R S ) (FR) | 2017-11-15 | — | — | EP | disclosed |
| US-8268801-B2 | Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2012-09-18 | — | — | US | disclosed |
| US-8268801-B2 | Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2012-09-18 | — | — | US | disclosed |
| US-20100166801-A1 | SULFOGLYCOLIPID ANTIGENS, THEIR PROCESS OF PREPARATION, AND THEIR USE AGAINST TUBERCULOSIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2010-07-01 | — | — | US | disclosed |
| US-20100166801-A1 | SULFOGLYCOLIPID ANTIGENS, THEIR PROCESS OF PREPARATION, AND THEIR USE AGAINST TUBERCULOSIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100166801-A1 | SULFOGLYCOLIPID ANTIGENS, THEIR PROCESS OF PREPARATION, AND THEIR USE AGAINST TUBERCULOSIS | FUT5, ALG1, FUT6 | LCK 1263/4885PPARD 937/4885ZDHHC20 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.